New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)
Form 144 | Phibro Animal Health(PAHC.US) 10% Stockholder Proposes to Sell 4.52 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Phibro Animal Health(PAHC.US)$ 10% Stockholder BFI Co., LLC intends to sell 257.4K shares of its common stock on May 13, with a total market value of approximately $4.
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2024 Earnings Call Transcript
Earnings Call Summary | Phibro Animal Health(PAHC.US) Q3 2024 Earnings Conference
The following is a summary of the Phibro Animal Health Corporation (PAHC) Q3 2024 Earnings Call Transcript:Financial Performance:Phibro Animal Health Corporation reported Q3 2024 net sales of $263.2 m
Phibro Animal Health Is Maintained at Underweight by Barclays
Phibro Animal Health Is Maintained at Underweight by Barclays
Barclays: Maintaining the Phibro Animal Health (PAHC.US) rating, adjusted from reduced holdings to reduced holdings rating, and adjusted the target price from $10.00 to $13.00.
Barclays: Maintaining the Phibro Animal Health (PAHC.US) rating, adjusted from reduced holdings to reduced holdings rating, and adjusted the target price from $10.00 to $13.00.
Barclays Maintains Underweight on Phibro Animal Health, Raises Price Target to $13
Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and raises the price target from $10 to $13.
Phibro Animal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 -26.55% Barclays $10 → $13 Maintains Underweight 11/09/2023 -9.6% Morgan Stanley $17 → $16 Main
Phibro Animal Health Corporation (PAHC) Q3 2024 Earnings Call Transcript
Phibro Animal Health Corporation (PAHC) Q3 2024 Earnings Call Transcript
Phibro Animal Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Phibro Animal Health To Go Ex-Dividend On June 5th, 2024 With 0.12 USD Dividend Per Share
May 10th - $Phibro Animal Health(PAHC.US)$ is trading ex-dividend on June 5th, 2024. Shareholders of record on June 5th, 2024 will receive 0.12 USD dividend per share on June 26th, 2024. The ex-di
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Phibro Animal Health (PAHC) and Amphastar Pharmaceuticals (AMPH)
Phibro Animal Health Affirms FY24 Adj. EPS $1.04-$1.16 Vs $1.10 Est.; Revenue $980M-$1.020B Vs $999.037M
Phibro Animal Health Affirms FY24 Adj. EPS $1.04-$1.16 Vs $1.10 Est.; Revenue $980M-$1.020B Vs $999.037M
Phibro Animal Health Q3 2024 Adj EPS $0.31 Beats $0.29 Estimate, Sales $263.200M Beat $254.825M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.29 by 6.9 percent. This is a 6.9 percent increase over earnings of $0.
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, Vs. Street Est of $0.29
04:47 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 Revenue $263.2M, Vs. Street Est of $253.7M
04:47 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 Revenue $263.2M, vs. Street Est of $253.7M
Phibro Animal Health Backs FY24 Sales $980M-$1B >PAHC
Phibro Animal Health Backs FY24 Sales $980M-$1B >PAHC
Phibro Animal Health Adjusts FY24 View To EPS 17C-EPS 30C >PAHC
Phibro Animal Health Adjusts FY24 View To EPS 17C-EPS 30C >PAHC
Phibro Animal Health 3Q Sales $263.2M >PAHC
Phibro Animal Health 3Q Sales $263.2M >PAHC
No Data